ID

38414

Descripción

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma; ODM derived from: https://clinicaltrials.gov/show/NCT01610544

Link

https://clinicaltrials.gov/show/NCT01610544

Palabras clave

Versiones (1)
  1. 16/10/19 16/10/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

16 de octubre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Carcinoma, Non-Small-Cell Lung NCT01610544

Inglés

Eligibility Carcinoma, Non-Small-Cell Lung NCT01610544

1 formularios  
Criteria
Descripción

Criteria

subjects with pathology proven lung cancer or thymic malignancy already enrolled in an nci treatment protocol usingazd6244 in nsclc and imc-a12, in thymoma.
Descripción

Carcinoma of lung | Malignant Neoplasm Thymic | Study Subject Participation Status | Treatment Protocols Specified | Non-Small Cell Lung Carcinoma | Thymoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0684249
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0040113
UMLS CUI [3]
C2348568
UMLS CUI [4,1]
C0040808
UMLS CUI [4,2]
C0205369
UMLS CUI [5]
C0007131
UMLS CUI [6]
C0040100
participant must be 18 years or older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance score of 0 to 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
ability to provide informed consent. all patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of this study before any protocol related studies are performed.
Descripción

Informed Consent | Comprehension Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C2348563
participants must not be pregnant or intend to become pregnant within 1 week of the last injection of (18)f flt
Descripción

Pregnancy Absent | Planned Pregnancy Absent | (18F) fluorothymidine Injection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0032992
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1432709
UMLS CUI [3,2]
C1533685
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known allergy to fluorothymidine
Descripción

Hypersensitivity (18F) fluorothymidine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1432709
participants for whom enrollment would significantly delay (> 2 weeks) the scheduled standard of care therapy
Descripción

Enrollment Causing Delay Standard of Care

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516879
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0205421
UMLS CUI [1,4]
C2936643
participants with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results are excluded
Descripción

Comorbidity Interferes with Procedure Investigational | Mental condition Interferes with Procedure Investigational | Comorbidity Interferes with Research results | Mental condition Interferes with Research results

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0184661
UMLS CUI [1,4]
C1517586
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0184661
UMLS CUI [2,4]
C1517586
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0683954
UMLS CUI [4,1]
C3840291
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0683954
participants with severe claustrophobia not relieved by oral anxiolytic medication or patients weighing > 136 kg (weight limit for scanner table)
Descripción

Claustrophobia Severe | Anti-Anxiety Agents Unsuccessful | Body Weight Inappropriate Scanner Device

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008909
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0040616
UMLS CUI [2,2]
C1272705
UMLS CUI [3,1]
C0005910
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C1710020
other medical conditions deemed by the pi or associates to make the patient ineligible for protocol procedures
Descripción

Other medical condition Ineligibility Protocol procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1512714
UMLS CUI [1,3]
C2348563
UMLS CUI [1,4]
C0184661
Volver a la parte superior de la página

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT01610544

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Carcinoma of lung | Malignant Neoplasm Thymic | Study Subject Participation Status | Treatment Protocols Specified | Non-Small Cell Lung Carcinoma | Thymoma
Item
subjects with pathology proven lung cancer or thymic malignancy already enrolled in an nci treatment protocol usingazd6244 in nsclc and imc-a12, in thymoma.
boolean
C0684249 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0040113 (UMLS CUI [2,2])
C2348568 (UMLS CUI [3])
C0040808 (UMLS CUI [4,1])
C0205369 (UMLS CUI [4,2])
C0007131 (UMLS CUI [5])
C0040100 (UMLS CUI [6])
Age
Item
participant must be 18 years or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance score of 0 to 2
boolean
C1520224 (UMLS CUI [1])
Informed Consent | Comprehension Study Protocol
Item
ability to provide informed consent. all patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of this study before any protocol related studies are performed.
boolean
C0021430 (UMLS CUI [1])
C0162340 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Pregnancy Absent | Planned Pregnancy Absent | (18F) fluorothymidine Injection
Item
participants must not be pregnant or intend to become pregnant within 1 week of the last injection of (18)f flt
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0032992 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1432709 (UMLS CUI [3,1])
C1533685 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity (18F) fluorothymidine
Item
known allergy to fluorothymidine
boolean
C0020517 (UMLS CUI [1,1])
C1432709 (UMLS CUI [1,2])
Enrollment Causing Delay Standard of Care
Item
participants for whom enrollment would significantly delay (> 2 weeks) the scheduled standard of care therapy
boolean
C1516879 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0205421 (UMLS CUI [1,3])
C2936643 (UMLS CUI [1,4])
Comorbidity Interferes with Procedure Investigational | Mental condition Interferes with Procedure Investigational | Comorbidity Interferes with Research results | Mental condition Interferes with Research results
Item
participants with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results are excluded
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C1517586 (UMLS CUI [1,4])
C3840291 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
C1517586 (UMLS CUI [2,4])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
Claustrophobia Severe | Anti-Anxiety Agents Unsuccessful | Body Weight Inappropriate Scanner Device
Item
participants with severe claustrophobia not relieved by oral anxiolytic medication or patients weighing > 136 kg (weight limit for scanner table)
boolean
C0008909 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0040616 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0005910 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1710020 (UMLS CUI [3,3])
Other medical condition Ineligibility Protocol procedure
Item
other medical conditions deemed by the pi or associates to make the patient ineligible for protocol procedures
boolean
C3843040 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial